ITOS - iTeos Therapeutics, Inc.
IEX Last Trade
7.31
0.030 0.410%
Share volume: 5,387
Last Updated: Fri 27 Dec 2024 08:30:03 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.25%
PREVIOUS CLOSE
CHG
CHG%
$7.28
0.03
0.41%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | |
| Report Date | 2022-05-12 | 2022-08-10 | 2022-11-10 | 2023-03-15 | 2023-05-10 | 2023-08-08 | 2023-11-07 | 2024-03-06 | |
| Total revenue | 152.522 M | 41.716 M | 19.487 M | 53.905 M | 12.595 M | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 152.522 M | 41.716 M | 19.487 M | 53.905 M | 12.595 M | 0.000 | 0.000 | 0.000 | |
| -72.65% | -53.29% | 176.62% | -76.63% | -100.00% | nan% | nan% | |||
| Operating expenses | 31.711 M | 38.381 M | 34.692 M | 36.522 M | 37.525 M | 42.621 M | 43.280 M | 40.270 M | |
| Selling general and admin | 10.615 M | 11.471 M | 10.760 M | 11.101 M | 11.927 M | 13.435 M | 12.642 M | 12.392 M | |
| Research and development | 21.096 M | 26.910 M | 23.932 M | 25.421 M | 25.598 M | 29.186 M | 30.638 M | 27.878 M | |
| Total expenses | 31.711 M | 38.381 M | 34.692 M | 36.522 M | 37.525 M | 42.621 M | 43.280 M | 40.270 M | |
| 21.03% | -9.61% | 5.27% | 2.75% | 13.58% | 1.55% | -6.95% | |||
| Operating income | 120.811 M | 3.335 M | -15.205 M | 17.383 M | -24.930 M | -42.621 M | -43.280 M | -40.270 M | |
| Ebit | 120.811 M | 3.335 M | -15.205 M | 17.383 M | -24.930 M | -42.621 M | -43.280 M | -40.270 M | |
| Pretax income | 119.533 M | 8.443 M | -1.986 M | 22.746 M | -14.352 M | -33.068 M | -33.422 M | -28.188 M | |
| -92.94% | -123.52% | -1,245.32% | -163.10% | 130.41% | 1.07% | -15.66% | |||
| Income tax | 49.951 M | 2.817 M | -2.977 M | 2.293 M | 1.199 M | 1.232 M | -1.181 M | 2.362 M | |
| Net income basic | 69.582 M | 5.626 M | 991.000 K | 20.453 M | -15.551 M | -34.300 M | -32.241 M | -30.550 M | |
| -91.91% | -82.39% | 1,963.87% | -176.03% | -120.56% | 6.00% | 5.24% | |||
| Net income | 69.582 M | 5.626 M | 991.000 K | 20.453 M | -15.551 M | -34.300 M | -32.241 M | -30.550 M | |
| -91.91% | -82.39% | 1,963.87% | -176.03% | -120.56% | 6.00% | 5.24% |